| Financial Year |
March 31 2023 |
| Monetary Funds |
12,746,618,656.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
65,368,358.96 |
| Accounts Receivable |
7,867,714,298.68 |
| Advances to Suppliers |
716,375,365.04 |
| Other Receivables |
55,580,870.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
827,647,687.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,345,080,792.39 |
| Total Current Assets |
23,640,382,915.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,787,901,278.35 |
| Investment Properties |
-- |
| Fixed Assetes |
40,722,779,025.55 |
| Under-construction Projects |
2,908,934,423.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
652,192,796.85 |
| Intangible Assets |
417,226,986.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
84,064,341.33 |
| Deferred Income Tax Assets |
170,694,062.84 |
| Other Non-Current Assets |
148,233,944.60 |
| Sub-Total of Non-Current Assets |
67,407,433,916.89 |
| Total Assets |
91,047,816,832.73 |
| Short-Term Loans |
6,785,552,588.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,173,598.00 |
| Accounts Payable |
5,976,120,055.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
55,726,603.53 |
| Taxes Payable |
262,098,031.13 |
| Interest Payable |
-- |
| Dividend Payable |
2,200,000.00 |
| Other payables |
422,808,853.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,341,023,742.55 |
| Other Current Liabilities |
5,042,106,301.37 |
| Sub-Total of Current Liabilities |
20,693,461,208.28 |
| Long-term Loans |
17,933,444,098.84 |
| Bonds Payable |
3,100,000,000.00 |
| Long-Term Accounts Payable |
1,663,137,913.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
705,705,357.97 |
| Deferred Income Tax Liabilities |
548,981,612.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,426,632,168.87 |
| Total Liabilities |
52,120,093,377.15 |
| Paid-In Capital(Or Share Stock) |
4,909,428,286.00 |
| Capital Surplus |
4,739,648,055.07 |
| Surplus Reserve |
15,162,939,439.34 |
| LESS:Treasury Stock |
120,296,670.00 |
| Undistributed Profits |
6,585,234,883.50 |
| Minority Stockholder's Interest |
7,281,265,146.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
31,646,458,309.36 |
| Owner's Equity（Stockholder's Equity） |
38,927,723,455.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
91,047,816,832.73 |
